The nation of Zimbabwe has rejected a major US healthcare agreement valued at 367 million US dollars (£272m) spanning five years because of the United States' insistence on confidential data.
This move came to light following a internal memorandum dated December was disclosed, which showed Head of State Emmerson Mnangagwa felt the arrangement was "lopsided".
A government representative later stated that the United States was seeking biological samples for research and profit while refused to guarantee the benefits from any future treatments.
"We will now turn to the difficult and regrettable process of scaling back our support in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont publicly.
The US Embassy said the United States had furnished over $1.9bn in health funding to Zimbabwe over the last twenty years.
A medical body in Zimbabwe has called for continued dialogue to find a deal suitable to both sides so the nation's vital HIV treatment initiative can proceed.
Wider Context
Zimbabwe's decision comes after a similar situation in Kenya, where a high court suspended a related health funding agreement following legal challenges were raised about the security of Kenyans' health data.
Since resuming office recently, US President Donald Trump has reduced overseas assistance and closed the key foreign aid agency.
The agency had overseen aid for the American government, but Trump argued its spending was "wasteful" and his administration was pursuing government-to-government agreements to boost transparency and responsibility.
As per reports, Sixteen African countries have to date agreed to these new health pacts, representing more than $18.3bn in new funding.
Specifics of the Rejected Agreement
This assistance for Zimbabwe was intended to gone towards "tackling HIV/Aids, TB, malaria, maternal and child health, and preparing for epidemics".
"We are confident this cooperation would have delivered significant benefits for Zimbabwean communities, particularly the 1.2 million men, women and children presently receiving antiretroviral therapy via American-funded initiatives," Tremont said.
However, official spokesman Nick Mangwana maintained the proposed deal was "unequal".
"The proposal required Zimbabwe to surrender its genetic material and health information indefinitely, with no equivalent promise of access to any scientific breakthroughs – like new medicines or tests – that could result from that provided information," Mangwana explained.
"In essence, our nation would provide the raw materials for scientific discovery with no assurance that the end products would be accessible to our people should a future pandemic arise."
National Interest and International Frameworks
He also pointed out that the American exit from the World Health Organization (WHO) and its pursuit of one-on-one deals were disrupting systems already set up via the international health agency.
Mangwana cited its Pathogen Access and Benefit Sharing system designed to deal with potential pandemics.
"This mechanism is designed to guarantee that when a nation provides its information, the benefits – such as vaccines and treatments – are shared equitably, not monopolised solely by those with the resources to create them."
The government's concerns regarding the US deal "should not be misconstrued as opposition to America," he added.
"We welcome further discussions with our American counterparts on how subsequent co-operation might be arranged in a manner that respects the sovereignty and dignity of both nations."
Health Experts Response
The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it recognised the government's concerns, but suggested that negotiations must proceed considering a large portion of the country's HIV programmes relied on international support.
"In cases where technical issues exist, including those involving data governance or implementation frameworks, these can often be resolved through technical clarification and negotiated safeguards," it commented.
The halted deal underscores the ongoing tensions between accepting vital foreign assistance and protecting a country's data in an increasingly interconnected world.